[조사자료] 글로벌 핵산 치료제 CDMO 시장 (2023-2030) : 프로세스 개발 및 최적화, 제조 서비스

■ 영문 제목 : Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type, By Service (Process Development & Optimization, Manufacturing Services), By End-user, By Application, By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV219 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 150 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의료 기기

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,330,000	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,730,000	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,530,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 핵산 치료제 CDMO 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 핵산 치료제 CDMO 시장 규모는 2023년부터 2030년까지 연평균 9. 4%의 성장률을 보이며 2030년에는 224억 2000만 달러에 달할 것으로 예상됩니다. 시장 성장의 주요 요인은 핵산 치료제에 대한 수요 증가, 핵산 기술의 발전, 핵산 치료제의 FDA 승인 증가, 비용 효율적인 위탁 개발 및 제조 서비스에 대한 수요 증가 등입니다.

생명 공학 기업, 제약회사, 학계의 유전자 치료제 연구개발에 대한 투자와 관심이 높아지면서 CDMO 서비스에 대한 수요가 증가하고 있으며, CDMO는 유전자 치료제 제조에서 중요한 역할을 하고 있습니다. 예를 들어, Catalent는 Sarepta Therapeutics의 상업적 제조 파트너로서 유전자 치료 솔루션을 추진하는 데 중요한 역할을 담당하고 있습니다.

코로나19 팬데믹 대응에서 mRNA 백신의 성공은 핵산 치료제의 잠재력을 보여주었고, 이 분야에 대한 추가 연구와 투자를 촉진했습니다. 예를 들어, 사노피는 2022년 3월 프랑스에서 메신저 RNA 백신 개발에 향후 몇 년 동안 10억 2,000만 달러(9억 3,500만 유로)를 투자할 계획을 발표했습니다. 사노피는 2021년 6월에 발표한 20억 유로 규모의 글로벌 투자 이니셔티브의 일환으로 2026년까지 이 투자를 진행할 예정입니다. 이 이니셔티브는 회사의 mRNA 전략을 촉진하기 위한 것으로 보입니다. 이러한 자금 조달 시나리오의 증가는 시장 성장을 촉진할 것으로 보입니다.

또한 CDMO 인수 및 제휴의 증가는 향후 몇 년 동안 핵산 치료제 CDMO의 시장 성장을 가속화 할 것으로 예상됩니다. 예를 들어, 2022년 5월 eureKARE는 세포 및 유전자치료제 위탁개발생산기관(CDMO)을 설립하기 위해 1억 6,098만 달러(1억 5,000만 유로) 규모의 합병을 시작했습니다.

회사는 유럽의 3개 CDMO를 통합하기 위해 특수목적회사(SPAC)인 유레킹(eureKING)을 설립했습니다. 또한, 후지필름은 2022년 4월 미국 캘리포니아에 위치한 Atara Biotherapeutics, Inc. 의 세포치료제 전문 제조시설을 인수하여 첨단 치료제 CDMO 포트폴리오를 확대했습니다. 이러한 노력은 시장 성장을 견인할 것으로 기대됩니다.

핵산 치료제 CDMO 시장 보고서 하이라이트

- 2022년 가장 큰 매출 점유율을 차지한 RNA 기반 치료제 부문은 RNA 기반 치료제(주로 mRNA)가 다양한 질병에 대한 다재다능함을 제공합니다. 다양한 치료용 단백질을 생산하도록 설계할 수 있기 때문에 다양한 치료 영역에 적용 가능합니다.

- 유전자 치료 분야는 향후 몇 년 동안 큰 시장 성장이 예상됩니다. 그 배경에는 유전자 치료의 임상적 성공이 있으며, 유전자 치료의 적응증 확대에 도움이 되고 있습니다.

- 2022년에는 제조 서비스 부문이 시장을 주도하며 전체 매출 점유율의 38% 이상을 차지할 것으로 예상됩니다. 이 부문의 성장에 기여하는 주요 요인으로는 복잡한 제조 공정, 규모 확대 및 생산 문제, 비용 효율성 등이 있습니다.

- 생명 공학 기업들은 혁신적인 치료법 연구개발에 많은 투자를 하고 있어 2022년 58% 이상의 주요 매출 점유율을 차지할 것으로 예상됩니다.

- 용도별로는 암 분야가 2022년 31.0% 이상의 매출 점유율로 세계 시장을 주도할 것으로 보입니다. 그 배경에는 유전자 치료와 RNA 기반 치료제의 채택이 증가하고 있으며, 암 분야 핵산 치료제 파이프라인이 증가하고 있기 때문으로 분석됩니다.

- 2022년 핵산 치료제 CDMO 시장에서는 북미가 38. 49%로 가장 큰 매출 점유율을 차지할 것으로 예상됩니다. 막대한 투자와 자금 지원, 강력한 학술 및 연구 기관, CDMO의 글로벌 확장이 이 지역의 성장을 촉진하고 있다고 전했습니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변동, 동향, 범위
Chapter 4. 세계의 핵산 치료제 CDMO 시장 : 유형별 예측 및 동향 분석
Chapter 5. 세계의 핵산 치료제 CDMO 시장 : 서비스별 예측 및 동향 분석
Chapter 6. 세계의 핵산 치료제 CDMO 시장 : 최종 용도별 예측 및 동향 분석
Chapter 7. 세계의 핵산 치료제 CDMO 시장 : 용도별 예측 및 동향 분석
Chapter 8. 세계의 핵산 치료제 CDMO 시장 : 지역별 예측 및 동향 분석
Chapter 9. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.5. Market Driver Analysis
3.6. Market Restraint Analysis
3.7. Business Environment Analysis
3.7.1. SWOT Analysis
3.7.2. Porter’s Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Nucleic Acid Therapeutics CDMO Market: Type Movement Analysis
4.2. Gene Therapy
4.2.1. Gene Therapy Market, 2018 – 2030 (USD Billion)
4.3. RNA-based Therapies
4.3.1. RNA-based Therapies Market, 2018 – 2030 (USD Billion)
Chapter 5. Service Business Analysis
5.1. Nucleic Acid Therapeutics CDMO Market: Service Movement Analysis
5.2. Process Development and Optimization
5.2.1. Process Development and Optimization Market, 2018 – 2030 (USD Billion)
5.3. Manufacturing Services
5.3.1. Manufacturing Services Market, 2018 – 2030 (USD Billion)
5.4. Analytical and Quality Control Services
5.4.1. Analytical and Quality Control Services Market, 2018 – 2030 (USD Billion)
5.5. Others
5.5.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 6. End Users Business Analysis
6.1. Nucleic Acid Therapeutics CDMO Market: End Users Movement Analysis
6.2. Pharmaceutical Companies
6.2.1. Pharmaceutical Companies Market, 2018 – 2030 (USD Billion)
6.3. Government & Academic Research Institutes
6.3.1. Government & Academic Research Institutes Market, 2018 – 2030 (USD Billion)
6.4. Biotech Companies
6.4.1. Biotech Companies Market, 2018 – 2030 (USD Billion)
Chapter 7. Application Business Analysis
7.1. Nucleic Acid Therapeutics CDMO Market: Application Movement Analysis
7.2. Oncology
7.2.1. Oncology Market, 2018 – 2030 (USD Billion)
7.3. Genetic Disorders
7.3.1. Genetic Disorders Market, 2018 – 2030 (USD Billion)
7.4. Infectious Diseases
7.4.1. Infectious Diseases Market, 2018 – 2030 (USD Billion)
7.5. Others
7.5.1. Others Market, 2018 – 2030 (USD Billion)
Chapter 8. Regional Business Analysis
8.1. Nucleic Acid Therapeutics CDMO Market Share by Region, 2022 & 2030
8.2. North America
8.2.1. North America Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Regulatory Framework
8.2.2.3. Competitive Scenario
8.2.2.4. U.S. Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Regulatory Framework
8.2.3.3. Competitive Scenario
8.2.3.4. Canada Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3. Europe
8.3.1. Europe Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. UK Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Germany Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. France Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Italy Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Spain Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.7. Sweden
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Sweden Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.8. Norway
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Norway Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.3.9. Denmark
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Denmark Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4. Asia Pacific
8.4.1. Asia Pacific Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Japan Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. China Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. India Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.5. Australia
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Australia Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. South Korea Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Thailand Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5. Latin America
8.5.1. Latin America Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Brazil Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Mexico Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Argentina Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6. MEA
8.6.1. MEA Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. South Africa Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Saudi Arabia Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. UAE Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Kuwait Nucleic Acid Therapeutics CDMO Market, 2018 – 2030 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.2.1. Mergers & Acquisitions
9.2.2. Collaborations
9.2.3. New Product Launches
9.3. Participant’s overview
9.3.1. Catalent
9.3.1.1. Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Thermo Fisher Scientific
9.3.2.1. Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Lonza
9.3.3.1. Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. FUJIFILM Diosynth Biotechnologies
9.3.4.1. Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Cognate BioServices
9.3.5.1. Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Eurofins Genomics
9.3.6.1. Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Sirion Biotech
9.3.7.1. Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Oxford Biomedica
9.3.8.1. Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Danaher (Aldevron)
9.3.9.1. Overview
9.3.9.2. Financial Performance
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives

List of Tables

Table 1 List of data sources
Table 2 Global Nucleic Acid Therapeutics CDMO Market, by region, 2018 - 2030 (USD Billion)
Table 3 Global Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 4 Global Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 5 Global Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 6 Global Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 7 North America Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 8 North America Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 9 North America Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 10 North America Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 11 North America Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 12 U.S. Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 13 U.S. Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 14 U.S. Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 15 U.S. Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 16 Canada Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 17 Canada Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 18 Canada Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 19 Canada Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 20 Europe Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 21 Europe Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 22 Europe Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 23 Europe Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 24 Europe Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 25 UK Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 26 UK Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 27 UK Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 28 UK Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 29 Germany Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 30 Germany Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 31 Germany Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 32 Germany Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 33 France Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 34 France Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 35 France Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 36 France Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 37 Italy Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 38 Italy Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 39 Italy Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 40 Italy Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 41 Spain Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 42 Spain Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 43 Spain Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 44 Sapin Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 45 Denmark Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 46 Denmark Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 47 Denmark Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 48 Denmark Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 49 Sweden Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 50 Sweden Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 51 Sweden Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 52 Sweden Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 53 Norway Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 54 Norway Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 55 Norway Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 56 Norway Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 57 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 58 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 59 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 60 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 61 Asia Pacific Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 62 Japan Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 63 Japan Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 64 Japan Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 65 Japan Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 66 China Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 67 China Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 68 China Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 69 China Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 70 India Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 71 India Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 72 India Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 73 India Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 74 South Korea Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 75 South Korea Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 76 South Korea Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 77 South Korea Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 78 Australia Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 79 Australia Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 80 Australia Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 81 Australia Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 82 Thailand Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 83 Thailand Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 84 Thailand Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 85 Thailand Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 86 Latin America Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 87 Latin America Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 88 Latin America Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 89 Latin America Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 90 Latin America Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 91 Brazil Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 92 Brazil Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 93 Brazil Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 94 Brazil Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 95 Mexico Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 96 Mexico Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 97 Mexico Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 98 Mexico Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 99 Argentina Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 100 Argentina Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 101 Argentina Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 102 Argentina Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 103 MEA Nucleic Acid Therapeutics CDMO Market, by country, 2018 - 2030 (USD Billion)
Table 104 MEA Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 105 MEA Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 106 MEA Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 107 MEA Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 108 South Africa Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 109 South Africa Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 110 South Africa Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 111 South Africa Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 112 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 113 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 114 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 115 Saudi Arabia Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 116 UAE Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 117 UAE Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 118 UAE Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 119 UAE Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 120 Kuwait Nucleic Acid Therapeutics CDMO Market, by type, 2018 - 2030 (USD Billion)
Table 121 Kuwait Nucleic Acid Therapeutics CDMO Market, by service, 2018 - 2030 (USD Billion)
Table 122 Kuwait Nucleic Acid Therapeutics CDMO Market, by End Users, 2018 - 2030 (USD Billion)
Table 123 Kuwait Nucleic Acid Therapeutics CDMO Market, by Application, 2018 - 2030 (USD Billion)
Table 124 Participant’s overview
Table 125 Financial performance
Table 126 Type benchmarking
Table 127 Strategic Initiatives

※본 조사보고서 [글로벌 핵산 치료제 CDMO 시장 (2023-2030) : 프로세스 개발 및 최적화, 제조 서비스] (코드 : GRV23NOV219) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 핵산 치료제 CDMO 시장 (2023-2030) : 프로세스 개발 및 최적화, 제조 서비스] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

글로벌 핵산 치료제 CDMO 시장 (2023-2030) : 프로세스 개발 및 최적화, 제조…

[이하, 관련 보고서 소개]

글로벌 재조합 단백질 치료제 CDMO 시장 (2023-2030) : 성장 호르몬, 인터페론, 백신, 면역 자극제
GRV23NOV236 / Grand View Research / 2023년 9월 / 글로벌 재조합 단백질 치료제 CDMO 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 재조합 단백질 치료제 CDMO 시장 규모는 2030년까지 519억 5000만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 재조합 단백질 치료제 CDMO 시장 : 유형별 예측 및 동향 분석 Chapter 5. 세계의 재조합 단백질 치료제 CDMO 시장 : 공급원별 예측 및 동향 분석 Chapter 6. 세계의 재조합 단백질 치료제 CDMO...

세계의 첨단 치료제 CDMO 시장 (2023-2030) : 유전자 치료, 세포 요법, 조직 공학
GRV23MA018 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 첨단 치료제 CDMO 시장 규모가 2023년부터 2030년 사이에 연평균 18.8% 성장하여, 2030년에는 188억 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 첨단 치료제...Advanced Therapy Medicinal Products CDMO Market Growth & Trends The global advanced therapy medicinal products CDMO market size is expected to reach USD 18.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 18.8% from 2023 to...

세계의 저분자 이노베이터 CDMO 시장 (2023~2030) : 저분자 원료 의약품, 저분자 의약품 제품
GRV23MR035 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 저분자 이노베이터 CDMO 시장 규모가 2023년부터 2030년 사이에 CAGR 6.4% 증가하여, 2030년에는 749억 달러에 이를 것으로 전망하고 있습니다. 본 자료는 세계의...Small Molecule Innovator CDMO Market Growth & Trends The global small molecule innovator CDMO market size is expected to reach USD 74.9 billion by 2030, expanding at 6.4% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. There is a growing interest among pharmaceutical...

글로벌 원료 의약품 CDMO 시장 (2023-2030) : 강력한 API, 항체 약물 접합체
GRV23NOV025 / Grand View Research / 2023년 9월 / 글로벌 원료 의약품 CDMO 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 원료 의약품 CDMO 시장 규모는 2030년까지 1,563억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 6....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 원료 의약품 CDMO 시장 : 제품별 분석 Chapter 5. 세계의 원료 의약품 CDMO 시장 : 합성별 분석 Chapter 6. 세계의 원료 의약품 CDMO 시장 : 약물별 분석 Chapter 7. 세계의 원료 의약품 CDMO 시장...

세계의 바이오 프로세스 검증 시장 (2023~2030) : 추출물 및 침출물 시험, 바이오 프로세스 잔류물 시험
GRV23MA021 / Grand View Research / 2023년 1월 / 미국 Grand View Research (그랜드뷰리서치)는 세계의 바이오 프로세스 검증 시장 규모가 2023년부터 2030년 사이에 연평균 9.1% 성장하여, 2030년에는 842.5백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 자료는 세계의 바이오 프로세스...Bioprocess validation Market Growth & Trends The global bioprocess validation market size is projected to reach USD 842.5 million by 2030, at a CAGR of 9.10% from 2023 to 2030, according to a new report by Grand View Research, Inc. Bioprocess validation is the process of documentation of all the...